Biomet Posts Narrower FQ4 Loss
Biomet reported a narrower fiscal fourth-quarter loss.
Biomet posted a quarterly loss of $388.1 million, versus a year-ago loss of $812.8 million. Excluding special items, Biomet's adjusted earnings surged to $105.6 million from $24.6 million.
Its net sales rose 3.4% to $739.5 million, while gross margin gained to 69.6% from 68%.
US sales climbed 6.8%, while sales in Europe declined 8.2%.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.